Eighteen Republican Senators urged the Trump Administration to utilize trade negotiations to reduce drug prices for citizens. They emphasized the need for filling the Chief Innovation and Intellectual Property Negotiator position to strengthen commitment in these areas. President Trump's Executive Order aims to significantly decrease drug prices with a most-favored-nation pricing strategy. While the senators supported this approach, they stressed that active engagement with trading partners is crucial to remove market-distorting controls. The ongoing vacancy in the negotiator position warrants immediate attention to facilitate these negotiations.
"Appointing an experienced Chief Innovation and Intellectual Property Negotiator would send a strong signal to our trading partners that the United States is committed to addressing imbalanced pharmaceutical pricing."
"Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before. Additionally, on top of everything else, the United States will save TRILLIONS OF DOLLARS."
#drug-pricing #intellectual-property #us-trade-negotiations #pharmaceutical-policy #political-advocacy
Collection
[
|
...
]